{"transactions":[{"id":2824,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":9991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":9991},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2823,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":6481,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6481},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2822,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."}],"balance_after":12475,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":6237},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2821,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":25826,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2820,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":120150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":120150,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":120150},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2819,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":30050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."}],"balance_after":30050,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":30050},"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2818,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":15144,"price":79.28,"value":1200616.32,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"balance_after":92348,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2817,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":8609,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":107492,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2816,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6237,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":98883,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2815,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6481,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":92646,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2814,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:48:15.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":9991,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":86165,"source":{"system":"sec-edgar","filing":"0001532218-26-000016","document":"form4-09032026_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000016/form4-09032026_080911.xml","form_type":"4"}},{"id":2793,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":9991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":9991},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2792,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":6481,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6481},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2791,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."}],"balance_after":12475,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":6237},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2790,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":25826,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2789,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":120150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":120150,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":120150},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2788,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":30050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."}],"balance_after":30050,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":30050},"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2787,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":15144,"price":79.28,"value":1200616.32,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"balance_after":92348,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2786,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":8609,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":107492,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2785,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6237,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":98883,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2784,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6481,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":92646,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":2783,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:46:21.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":9991,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":86165,"source":{"system":"sec-edgar","filing":"0001532218-26-000014","document":"form4-09032026_080914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000014/form4-09032026_080914.xml","form_type":"4"}},{"id":754854,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class B Ordinary Shares","published_at":"2026-06-02T20:50:02.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"The Anglia 2013 Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."}],"balance_after":626160,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001532218-26-000012","document":"form4-06022026_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000012/form4-06022026_080657.xml","form_type":"4"}},{"id":754853,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:50:02.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":900000,"ownership":{"direct":false,"nature":"The Anglia 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party."}],"balance_after":951794,"source":{"system":"sec-edgar","filing":"0001532218-26-000012","document":"form4-06022026_080657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000012/form4-06022026_080657.xml","form_type":"4"}},{"id":795724,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-05-01T20:32:22.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":48565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":30.93,"expiration_date":"2028-09-19","underlying":"Class A Ordinary Share","underlying_shares":48565},"source":{"system":"sec-edgar","filing":"0001532218-26-000008","document":"form4-05012026_080517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000008/form4-05012026_080517.xml","form_type":"4"}},{"id":795723,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-05-01T20:32:22.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":48565,"price":54.02,"value":2623481.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.155. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001532218-26-000008","document":"form4-05012026_080517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000008/form4-05012026_080517.xml","form_type":"4"}},{"id":795722,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-05-01T20:32:22.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":48565,"price":30.93,"value":1502115.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."}],"balance_after":48565,"source":{"system":"sec-edgar","filing":"0001532218-26-000008","document":"form4-05012026_080517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000008/form4-05012026_080517.xml","form_type":"4"}},{"id":796891,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-30","kind":"exercise","planned":true,"acquired":false,"shares":2141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":48565,"derivative":{"exercise_price":30.93,"expiration_date":"2028-09-19","underlying":"Class A Ordinary Share","underlying_shares":2141},"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796890,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-29","kind":"exercise","planned":true,"acquired":false,"shares":22544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":50706,"derivative":{"exercise_price":30.93,"expiration_date":"2028-09-19","underlying":"Class A Ordinary Share","underlying_shares":22544},"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796889,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"exercise","planned":true,"acquired":false,"shares":51750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":73250,"derivative":{"exercise_price":30.93,"expiration_date":"2028-09-19","underlying":"Class A Ordinary Share","underlying_shares":51750},"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796888,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"exercise","planned":true,"acquired":false,"shares":431904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.36,"expiration_date":"2028-02-29","underlying":"Class A Ordinary Share","underlying_shares":431904},"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796887,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":2141,"price":54.01,"value":115635.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796886,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-30","kind":"exercise","planned":true,"acquired":true,"shares":2141,"price":30.93,"value":66221.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."}],"balance_after":2141,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796885,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-29","kind":"sale","planned":true,"acquired":false,"shares":22544,"price":54.01,"value":1217601.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.225. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796884,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-29","kind":"exercise","planned":true,"acquired":true,"shares":22544,"price":30.93,"value":697285.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."}],"balance_after":22544,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796883,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":51750,"price":54.02,"value":2795535.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.22. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796882,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":243596,"price":52.02,"value":12671863.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $52.00 and $52.58. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":51750,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796881,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":113673,"price":51.47,"value":5850749.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $51.00 and $51.99. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":295346,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796880,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":74635,"price":50.43,"value":3763843.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.985. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":409019,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796879,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"exercise","planned":true,"acquired":true,"shares":51750,"price":30.93,"value":1600627.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."}],"balance_after":483654,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":796878,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-30T22:33:04.000Z","date":"2026-04-28","kind":"exercise","planned":true,"acquired":true,"shares":431904,"price":10.36,"value":4474525.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."}],"balance_after":431904,"source":{"system":"sec-edgar","filing":"0001532218-26-000006","document":"form4-04302026_100400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000006/form4-04302026_100400.xml","form_type":"4"}},{"id":812572,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-04-08T20:43:07.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":false,"shares":9991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSs vesting on the yearly anniversary of the grant date, April 7, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSs vesting on the yearly anniversary of the grant date, April 7, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":9991},"source":{"system":"sec-edgar","filing":"0001532218-26-000004","document":"form4-04082026_080403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000004/form4-04082026_080403.xml","form_type":"4"}},{"id":812571,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-04-08T20:43:07.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":7278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":431904,"derivative":{"exercise_price":10.36,"expiration_date":"2028-02-29","underlying":"Class A Ordinary Share","underlying_shares":7278},"source":{"system":"sec-edgar","filing":"0001532218-26-000004","document":"form4-04082026_080403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000004/form4-04082026_080403.xml","form_type":"4"}},{"id":812570,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:43:07.000Z","date":"2026-04-07","kind":"tax_withholding","planned":true,"acquired":false,"shares":4831,"price":48.94,"value":236429.14,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"balance_after":76174,"source":{"system":"sec-edgar","filing":"0001532218-26-000004","document":"form4-04082026_080403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000004/form4-04082026_080403.xml","form_type":"4"}},{"id":812569,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:43:07.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":true,"shares":9991,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":81005,"source":{"system":"sec-edgar","filing":"0001532218-26-000004","document":"form4-04082026_080403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000004/form4-04082026_080403.xml","form_type":"4"}},{"id":812568,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:43:07.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":7278,"price":50.01,"value":363972.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.005 and $50.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001532218-26-000004","document":"form4-04082026_080403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000004/form4-04082026_080403.xml","form_type":"4"}},{"id":812567,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:43:07.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":7278,"price":10.36,"value":75400.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025."}],"balance_after":7278,"source":{"system":"sec-edgar","filing":"0001532218-26-000004","document":"form4-04082026_080403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000004/form4-04082026_080403.xml","form_type":"4"}},{"id":816529,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025."}],"balance_after":25826,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":816528,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":6237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024."}],"balance_after":12475,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6237},"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":816527,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":6481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023."}],"balance_after":6481,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6481},"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":816526,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Performance Share Unit","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":60100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":60100,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":60100},"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":816525,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":30050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter."}],"balance_after":30050,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":30050},"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":816524,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":120150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026."}],"balance_after":120150,"derivative":{"exercise_price":48.13,"expiration_date":"2036-03-31","underlying":"Class A Ordinary Share","underlying_shares":120150},"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":816523,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":10313,"price":48.13,"value":496364.69,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"balance_after":71014,"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":816522,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2026-04-03T20:39:03.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":21327,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":81327,"source":{"system":"sec-edgar","filing":"0001532218-26-000002","document":"form4-04032026_080457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221826000002/form4-04032026_080457.xml","form_type":"4"}},{"id":998923,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-11-14T21:38:53.000Z","date":"2025-11-13","kind":"gift","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The Patel Family Irrevocable Trust of 2025"},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001532218-25-000007","document":"form4-11142025_091149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000007/form4-11142025_091149.xml","form_type":"4"}},{"id":998922,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-11-14T21:38:53.000Z","date":"2025-11-13","kind":"gift","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The Anglia 2013 Revocable Trust"},"balance_after":51794,"source":{"system":"sec-edgar","filing":"0001532218-25-000007","document":"form4-11142025_091149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000007/form4-11142025_091149.xml","form_type":"4"}},{"id":998921,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-11-14T21:38:53.000Z","date":"2025-11-12","kind":"gift","planned":false,"acquired":true,"shares":111794,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The Anglia 2013 Revocable Trust"},"balance_after":111794,"source":{"system":"sec-edgar","filing":"0001532218-25-000007","document":"form4-11142025_091149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000007/form4-11142025_091149.xml","form_type":"4"}},{"id":998920,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-11-14T21:38:53.000Z","date":"2025-11-12","kind":"gift","planned":false,"acquired":false,"shares":111794,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001532218-25-000007","document":"form4-11142025_091149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000007/form4-11142025_091149.xml","form_type":"4"}},{"id":1014736,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-22","kind":"exercise","planned":true,"acquired":false,"shares":97390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2027-06-28","underlying":"Class A Ordinary Share","underlying_shares":97390},"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014735,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-21","kind":"exercise","planned":true,"acquired":false,"shares":39331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":97390,"derivative":{"exercise_price":3.8,"expiration_date":"2027-06-28","underlying":"Class A Ordinary Share","underlying_shares":39331},"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014734,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":121248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":136721,"derivative":{"exercise_price":3.8,"expiration_date":"2027-06-28","underlying":"Class A Ordinary Share","underlying_shares":121248},"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014733,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-22","kind":"sale","planned":true,"acquired":false,"shares":97390,"price":38.83,"value":3781653.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.495 and $39.255. The price reported in this column reflects a weighted sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":111794,"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014732,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-22","kind":"exercise","planned":true,"acquired":true,"shares":97390,"price":3.8,"value":370082.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."}],"balance_after":209184,"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014731,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-21","kind":"sale","planned":true,"acquired":false,"shares":39331,"price":38.77,"value":1524862.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.49 and $39.235. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":111794,"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014730,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-21","kind":"exercise","planned":true,"acquired":true,"shares":39331,"price":3.8,"value":149457.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."}],"balance_after":151125,"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014729,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":22314,"price":39.32,"value":877386.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.14 and $39.55. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":111794,"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014728,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":98934,"price":38.81,"value":3839628.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.14 and $39.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":134108,"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1014727,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:09:09.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":121248,"price":3.8,"value":460742.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 7, 2025."}],"balance_after":233042,"source":{"system":"sec-edgar","filing":"0001532218-25-000005","document":"form4-10222025_091005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000153221825000005/form4-10222025_091005.xml","form_type":"4"}},{"id":1049749,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-02","kind":"exercise","planned":false,"acquired":false,"shares":6569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6569},"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049748,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":9992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":9991,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":9992},"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049747,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":12962,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":6481},"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049746,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":6238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024."}],"balance_after":18712,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":6238},"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049745,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":137638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025."}],"balance_after":137638,"derivative":{"exercise_price":33.49,"expiration_date":"2035-08-31","underlying":"Class A Ordinary Share","underlying_shares":137638},"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049744,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":34435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":34435,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":34435},"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049743,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3177,"price":34.28,"value":108907.56,"ownership":{"direct":true},"balance_after":111794,"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049742,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-02","kind":"exercise","planned":false,"acquired":true,"shares":6569,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":114971,"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049741,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":10983,"price":33.49,"value":367820.67,"ownership":{"direct":true},"balance_after":108402,"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049740,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":true,"shares":9992,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":119385,"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049739,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6481,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":109393,"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1049738,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:44:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":true,"shares":6238,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":102912,"source":{"system":"sec-edgar","filing":"0001415889-25-023550","document":"form4-09032025_080927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023550/form4-09032025_080927.xml","form_type":"4"}},{"id":1131932,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-28","kind":"exercise","planned":true,"acquired":false,"shares":62116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":62116},"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131931,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-27","kind":"exercise","planned":true,"acquired":false,"shares":19317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":62116,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":19317},"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131930,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-23","kind":"exercise","planned":true,"acquired":false,"shares":4837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":81433,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":4837},"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131929,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-28","kind":"sale","planned":true,"acquired":false,"shares":62116,"price":27.33,"value":1697630.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.76. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":96674,"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131928,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-28","kind":"exercise","planned":true,"acquired":true,"shares":62116,"price":1.59,"value":98764.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."}],"balance_after":158790,"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131927,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-27","kind":"sale","planned":true,"acquired":false,"shares":19317,"price":27.01,"value":521752.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.06. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":96674,"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131926,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-27","kind":"exercise","planned":true,"acquired":true,"shares":19317,"price":1.59,"value":30714.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."}],"balance_after":115991,"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131925,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-23","kind":"sale","planned":true,"acquired":false,"shares":4837,"price":27,"value":130599.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":96674,"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1131924,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-28T21:25:05.000Z","date":"2025-05-23","kind":"exercise","planned":true,"acquired":true,"shares":4837,"price":1.59,"value":7690.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."}],"balance_after":101511,"source":{"system":"sec-edgar","filing":"0001415889-25-014744","document":"form4-05282025_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014744/form4-05282025_050501.xml","form_type":"4"}},{"id":1137229,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-22T20:38:27.000Z","date":"2025-05-20","kind":"exercise","planned":true,"acquired":false,"shares":2349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":86270,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":2349},"source":{"system":"sec-edgar","filing":"0001415889-25-014167","document":"form4-05222025_080524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014167/form4-05222025_080524.xml","form_type":"4"}},{"id":1137228,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-22T20:38:27.000Z","date":"2025-05-20","kind":"sale","planned":true,"acquired":false,"shares":2349,"price":27.02,"value":63469.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.04. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":96674,"source":{"system":"sec-edgar","filing":"0001415889-25-014167","document":"form4-05222025_080524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014167/form4-05222025_080524.xml","form_type":"4"}},{"id":1137227,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-22T20:38:27.000Z","date":"2025-05-20","kind":"exercise","planned":true,"acquired":true,"shares":2349,"price":1.59,"value":3734.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."}],"balance_after":99023,"source":{"system":"sec-edgar","filing":"0001415889-25-014167","document":"form4-05222025_080524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925014167/form4-05222025_080524.xml","form_type":"4"}},{"id":1147396,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-15T20:39:37.000Z","date":"2025-05-13","kind":"exercise","planned":true,"acquired":false,"shares":2872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":88619,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":2872},"source":{"system":"sec-edgar","filing":"0001415889-25-013170","document":"form4-05152025_080533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925013170/form4-05152025_080533.xml","form_type":"4"}},{"id":1147395,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-15T20:39:37.000Z","date":"2025-05-13","kind":"sale","planned":true,"acquired":false,"shares":2872,"price":27.03,"value":77630.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.06. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":96674,"source":{"system":"sec-edgar","filing":"0001415889-25-013170","document":"form4-05152025_080533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925013170/form4-05152025_080533.xml","form_type":"4"}},{"id":1147394,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-15T20:39:37.000Z","date":"2025-05-13","kind":"exercise","planned":true,"acquired":true,"shares":2872,"price":1.59,"value":4566.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."}],"balance_after":99546,"source":{"system":"sec-edgar","filing":"0001415889-25-013170","document":"form4-05152025_080533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925013170/form4-05152025_080533.xml","form_type":"4"}},{"id":1153766,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-09T21:32:14.000Z","date":"2025-05-09","kind":"exercise","planned":true,"acquired":false,"shares":6029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":91491,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":6029},"source":{"system":"sec-edgar","filing":"0001415889-25-012571","document":"form4-05092025_090511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012571/form4-05092025_090511.xml","form_type":"4"}},{"id":1153765,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-09T21:32:14.000Z","date":"2025-05-08","kind":"exercise","planned":true,"acquired":false,"shares":101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":97520,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":101},"source":{"system":"sec-edgar","filing":"0001415889-25-012571","document":"form4-05092025_090511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012571/form4-05092025_090511.xml","form_type":"4"}},{"id":1153764,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Share Option","published_at":"2025-05-09T21:32:14.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":false,"shares":1965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":97621,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Ordinary Share","underlying_shares":1965},"source":{"system":"sec-edgar","filing":"0001415889-25-012571","document":"form4-05092025_090511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012571/form4-05092025_090511.xml","form_type":"4"}},{"id":1153763,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":2002,"kind":"person","name":"Patel Sanj K","position":1,"cik":"0001532218","reported_name":"Patel Sanj K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN & CEO"}}],"security":"Class A Ordinary Share","published_at":"2025-05-09T21:32:14.000Z","date":"2025-05-09","kind":"sale","planned":true,"acquired":false,"shares":6029,"price":27.05,"value":163084.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.03 and $27.14. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":96674,"source":{"system":"sec-edgar","filing":"0001415889-25-012571","document":"form4-05092025_090511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012571/form4-05092025_090511.xml","form_type":"4"}}],"next_cursor":"2025-05-09T21:32:14.000000Z,1153763"}